Folgen
Zaina Qureshi
Zaina Qureshi
Assistant Professor, Arnold School of Public Health, University of South Carolina
Bestätigte E-Mail-Adresse bei mailbox.sc.edu
Titel
Zitiert von
Zitiert von
Jahr
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
ZP Qureshi, E Seoane‐Vazquez, R Rodriguez‐Monguio, KB Stevenson, ...
Pharmacoepidemiology and drug safety 20 (7), 772-777, 2011
1882011
Regulatory and clinical considerations for biosimilar oncology drugs
CL Bennett, B Chen, T Hermanson, MD Wyatt, RM Schulz, ...
The Lancet Oncology 15 (13), e594-e605, 2014
1292014
A flexible, computationally efficient method for fitting the proportional hazards model to interval-censored data
L Wang, CS McMahan, MG Hudgens, ZP Qureshi
Biometrics 72 (1), 222-231, 2016
1242016
Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease
CL Bennett, ZP Qureshi, AO Sartor, LAB Norris, A Murday, S Xirasagar, ...
Clinical kidney journal 5 (1), 82-88, 2012
992012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)
S Jacob, BL Dunn, ZP Qureshi, N Bandarenko, HC Kwaan, DK Pandey, ...
Seminars in thrombosis and hemostasis 38 (08), 845-853, 2012
932012
Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
M Matsumoto, CL Bennett, A Isonishi, Z Qureshi, Y Hori, M Hayakawa, ...
PloS one 7 (3), e33029, 2012
912012
Effects of women’s autonomy on maternal healthcare utilization in Bangladesh: Evidence from a national survey
MR Haider, ZP Qureshi, MM Khan
Sexual & reproductive healthcare 14, 40-47, 2017
642017
A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern …
CL Bennett, DM Spiegel, IC Macdougall, LA Norris, ZP Qureshi, O Sartor, ...
Seminars in thrombosis and hemostasis 38 (08), 783-796, 2012
512012
Generic oncology drugs: are they all safe?
YT Yang, S Nagai, BK Chen, ZP Qureshi, AA Lebby, S Kessler, ...
The lancet oncology 17 (11), e493-e501, 2016
502016
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
Q Long, OT Oladapo, S Leathersich, JP Vogel, G Carroli, P Lumbiganon, ...
BJOG: An International Journal of Obstetrics & Gynaecology 124 (12), 1883-1890, 2017
452017
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye’s syndrome. a report from the Southern Network on Adverse …
CL Bennett, KM Starko, HS Thomsen, S Cowper, O Sartor, IC Macdougall, ...
Journal of general internal medicine 27, 1697-1703, 2012
412012
Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States
PB Bookstaver, CM Bland, ZP Qureshi, CM Faulkner‐Fennell, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (12 …, 2013
402013
Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network.
K Kaur, R Fayad, A Saxena, N Frizzell, A Chanda, S Das, S Chatterjee, ...
The Journal of community and supportive oncology 14 (2), 54-65, 2016
392016
Polysorbate 80 hypersensitivity reactions: a renewed call to action
LAB Norris, ZP Qureshi, PB Bookstaver, DW Raisch, O Sartor, H Chen, ...
Community Oncology 9 (7), 425-428, 2010
382010
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication
DW Raisch, W Campbell, V Garg, ZP Qureshi, PB Bookstaver, LAB Norris, ...
Expert Opinion on Drug Safety 10 (4), 521-528, 2011
362011
Rituximab and biosimilars–equivalence and reciprocity
ZP Qureshi, JS Magwood, S Singh, CL Bennett
Biosimilars, 19-25, 2013
322013
Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR)
CL Bennett, S Jacob, BL Dunn, P Georgantopoulos, XL Zheng, ...
British journal of haematology 161 (6), 896, 2013
322013
Development and feasibility of an academic detailing intervention to improve prescription drug monitoring program use among physicians
KS Barth, S Ball, RS Adams, R Nikitin, NR Wooten, ZP Qureshi, ...
Journal of Continuing Education in the Health Professions 37 (2), 98-105, 2017
302017
WHO Multicountry Survey on Maternal Newborn Health Research Network. Overview of abortion cases with severe maternal outcomes in the WHO Multicountry Survey on Maternal and …
M Dragoman, WR Sheldon, Z Qureshi, J Blum, B Winikoff, B Ganatra
BJOG 121 (Suppl 1), 25-31, 2014
302014
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
RA Sabol, V Noxon, O Sartor, JR Berger, Z Qureshi, DW Raisch, ...
Cancer Medicine 6 (7), 1541-1551, 2017
292017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20